| Marmota Limited (MEU) ORDINARY FULLY PAID |
Energy |
$136 |
Greenewood gold - Maiden drill program to commence
|
2 Jul 2025 8:23AM |
$0.040 |
$0.105 |
risen by
162.50%
|
|
MEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Marmota Limited is launching a maiden drill program at the Greenewood gold discovery.
- Greenewood is located on MEU’s tenement in the Gawler Craton, South Australia.
- The discovery lies about 5km north of the Aurora Tank gold project.
- The drill program will consist of approximately 40 holes targeting high-priority prospects.
- Targets were identified using auger drilling and geochemical analysis.
- Early exploration results at Greenewood have been promising.
- This initiative is part of Marmota’s broader gold exploration strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sandfire Resources Limited (SFR) ORDINARY FULLY PAID |
Materials |
$7,610 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:23AM |
$11.120 |
$16.310 |
risen by
46.67%
|
|
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
Statement of CDIs on issue - 5EA
|
2 Jul 2025 8:23AM |
$0.500 |
$0.230 |
fallen by
54%
|
|
| James Hardie Industries Plc (JHX) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$12,528 |
Appointment of New Non-Executive Directors & ATO Ruling
|
2 Jul 2025 8:23AM |
$40.770 |
$29.100 |
fallen by
28.62%
|
|
| Deterra Royalties Limited (DRR) ORDINARY FULLY PAID |
Materials |
$2,181 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:22AM |
$3.760 |
$4.120 |
risen by
9.57%
|
|
| Gumtree Australia Markets Limited (GUM) ORDINARY FULLY PAID |
Communication Services |
$40 |
Change in substantial holding
|
2 Jul 2025 8:22AM |
$0.095 |
$0.125 |
risen by
31.58%
|
|
| West African Resources Limited (WAF) ORDINARY FULLY PAID |
Materials |
$3,370 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:22AM |
$2.290 |
$2.950 |
risen by
28.82%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$3,575 |
Notice of Proposed Sale of Securities
|
2 Jul 2025 8:22AM |
$102.330 |
$97.380 |
fallen by
4.84%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$3,365 |
Form 8-K, Items 8.01 and 9.01
|
2 Jul 2025 8:22AM |
$45.030 |
$87.480 |
risen by
94.27%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,611 |
Net Tangible Asset Backing
|
2 Jul 2025 8:21AM |
$2.870 |
$4.120 |
risen by
43.55%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$384 |
Change of Director's Interest Notice - James Calaway
|
2 Jul 2025 8:21AM |
$0.098 |
$0.125 |
risen by
27.55%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$384 |
Change of Director's Interest Notice - Bernard Rowe
|
2 Jul 2025 8:21AM |
$0.098 |
$0.125 |
risen by
27.55%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$552 |
Updated Pre-Feasibility Study Presentation
|
2 Jul 2025 8:21AM |
$0.535 |
$0.560 |
risen by
4.67%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$384 |
Notification of cessation of securities - INR
|
2 Jul 2025 8:21AM |
$0.098 |
$0.125 |
risen by
27.55%
|
|
| Vault Minerals Limited (VAU) ORDINARY FULLY PAID |
Materials |
$4,645 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:21AM |
$0.420 |
$4.490 |
risen by
969.05%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$460 |
Notification of cessation of securities - CUV
|
2 Jul 2025 8:21AM |
$10.120 |
$9.120 |
fallen by
9.88%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$384 |
Application for quotation of securities - INR
|
2 Jul 2025 8:21AM |
$0.098 |
$0.125 |
risen by
27.55%
|
|
| Pancontinental Energy NL (PCL) ORDINARY FULLY PAID |
Energy |
$116 |
PEL 87 Technical Update
|
2 Jul 2025 8:21AM |
$0.011 |
$0.014 |
risen by
27.27%
|
|
PCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Technical update on PEL 87 offshore Namibia released by Pancontinental Energy NL.
- The Saturn Turbidite Complex within PEL 87 is identified as a key prospective area.
- Seismic interpretation indicates significant reservoir potential, similar to neighboring discoveries.
- Recent regional drilling successes have increased interest and de-risked the area.
- Pancontinental is conducting further technical studies and seeking farmout partners.
- PEL 87 is positioned within a proven oil fairway, enhancing exploration confidence.
- The company is preparing for a potential drilling campaign pending successful farmout and technical results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$165 |
Key Developments in Pivotal Trial & Innovation Study
|
2 Jul 2025 8:21AM |
$1.745 |
$1.780 |
risen by
2.01%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- EMvision Medical Devices Limited (EMV) provided a comprehensive update on key developments related to its pivotal clinical trial and innovation study.
- The pivotal trial aims to validate the efficacy and safety of EMVision's portable brain scanner for stroke diagnosis and monitoring.
- The trial has commenced with recruitment, and the company has emphasized the importance of achieving sufficient patient enrolment to meet regulatory and clinical endpoints.
- Initial feedback from trial sites has been positive, with clinicians noting the potential impact of the EMVision device on acute stroke care pathways.
- The company highlighted ongoing collaboration with major Australian hospitals and international clinical partners.
- Data from the pivotal trial will inform regulatory submissions and commercial strategy for market entry.
- EMVision is also running an innovation study focused on expanding the device’s applications beyond stroke, including traumatic brain injury and neurological monitoring.
- The innovation study involves advanced imaging algorithms and integration with other clinical data sources to enhance diagnostic performance.
- EMVision reported progress on device manufacturing scale-up and quality management processes to prepare for commercial deployment.
- The company’s management reiterated commitment to transparency with stakeholders and regular communication as the pivotal trial and innovation study progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$16,815 |
144 Report of proposed sale of securities
|
2 Jul 2025 8:21AM |
$39.050 |
$29.780 |
fallen by
23.74%
|
|
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$27 |
High Grade Antimony and Production Potential at Los Lirios
|
2 Jul 2025 8:21AM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- EV Resources Limited identified high-grade antimony mineralization at Los Lirios in Peru.
- Surface and underground channel samples show up to 56.5% Sb and confirm potential for production.
- Extensive mapping and historical mining data indicate robust mineralization and favorable widths.
- Plans include metallurgical testing and securing offtake agreements to fast-track development.
- Los Lirios has potential to contribute to critical antimony supply for energy and defense markets.
- Advancement to development stage is a priority for EV Resources based on strong sampling results.
- Los Lirios project supports EV Resources' strategic position in critical minerals sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
Notification regarding unquoted securities - 5EA
|
2 Jul 2025 8:20AM |
$0.500 |
$0.230 |
fallen by
54%
|
|
| abrdn Sustainable Asian Opportunities Active ETF (Managed Fund) (ASAO) |
Financials |
$2 |
Dividend Details
|
2 Jul 2025 8:20AM |
$1.210 |
$1.485 |
risen by
22.73%
|
|
| Critical Resources Limited (CRR) ORDINARY FULLY PAID |
Materials |
$26 |
Petrology Confirms Orogenic Gold-Antimony System at Amoco
|
2 Jul 2025 8:20AM |
$0.003 |
$0.008 |
risen by
166.67%
|
|
CRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Petrological studies confirm an orogenic gold-antimony system at the Amoco prospect.
- The Amoco prospect is part of the Halls Peak Project in New South Wales, Australia.
- Gold and antimony mineralization is linked to orogenic geological processes.
- Findings support targeted exploration strategies for gold and antimony.
- Confirmation of gold-antimony system expands potential resource inventory beyond base metals.
- Critical Resources Limited views this as a significant development for the project’s future.
- Petrology results provide new exploration targets and potential for resource growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| James Hardie Industries Plc (JHX) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$12,528 |
James Hardie Completes Acquisition of AZEK
|
2 Jul 2025 8:20AM |
$40.770 |
$29.100 |
fallen by
28.62%
|
|
JHX - Price-sensitive ASX Announcement
Full Release
Key Points
- James Hardie completed its acquisition of The AZEK Company.
- The acquisition was a cash-and-stock transaction valued at $8.4 billion.
- James Hardie aims to become a leading provider of exterior home and outdoor living solutions.
- Significant commercial and cost synergies are expected from the combination of the two companies.
- The acquisition will enhance James Hardie’s revenue, EBITDA growth, and free cash flow generation.
- The transaction strengthens James Hardie's portfolio with brands like Hardie, TimberTech, and AZEK Exteriors.
- James Hardie's ordinary shares are now listed on the NYSE under the symbol 'JHX'.
- Leadership changes include new roles for Aaron Erter as CEO and Rachel Wilson as CFO.
- AZEK stock has ceased trading on the NYSE post-acquisition.
- James Hardie will provide guidance on the acquisition's contribution to fiscal year 2026 results during their first quarter earnings call.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
